Evidence map›Paper›PMID 36384807›Full record

ArticleImplementation science : IS2022

Economic evaluation of implementation science outcomes in low- and middle-income countries: a scoping review.

Akash Malhotra, Ryan R Thompson, Faith Kagoya, Felix Masiye, Peter Mbewe, Mosepele Mosepele, Jane Phiri, Jairos Sambo, Abigail Barker, Drew B Cameron and 8 more

Abstract readScoping Review
In one paragraph

Article in Implementation science : IS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Akash Malhotra *Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Ryan R Thompson *Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID 0000-0001-6965-7770
Faith KagoyaInfectious Diseases Research Collaboration, Kampala, Uganda.
Felix MasiyeUniversity of Zambia, Lusaka, Zambia.
Peter MbeweCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Mosepele MosepeleUniversity of Botswana, Gaborone, Botswana.
Jane PhiriEzintsha, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.
Jairos SamboCavendish University Zambia, Lusaka, Zambia.
Abigail BarkerWashington University in Saint Louis, Saint Louis, MO, USA.
Drew B CameronDepartment of Health Policy and Management, Yale School of Public Health, New Haven, CT, USA.
Victor G Davila-RomanWashington University in Saint Louis, Saint Louis, MO, USA.
William EffahWashington University in Saint Louis, Saint Louis, MO, USA.
Brian HutchinsonCenter for Global Noncommunicable Diseases, RTI International, Seattle, WA, USA.
Michael LaxyTechnical University of Munich, Munich, Germany.
Brad NewsomeFogarty International Center (FIC), National Institutes of Health (NIH), Bethesda, MD, USA.
David WatkinsUniversity of Washington, Seattle, WA, USA.
Hojoon SohnDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, South Korea.
David W DowdyDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. ddowdy1@jhmi.edu.

Funding

Supplement: Implementation Research Strategies for Heart, Lung, and Blood Co-morbidities in People Living with HIV - Research Coordinating CenterU24HL154426 · NHLBI · WASHINGTON UNIVERSITY · PI DAVILA-ROMAN, VICTOR G., GENG, ELVIN H. · 2020 to 2024
$9.5M
Integrating HIV and hEART health in South Africa (iHeart-SA)UG3HL156388 · NHLBI · WITS HEALTH CONSORTIUM (PTY), LTD · PI ALI, MOHAMMED KUMAIL, MARCONI, VINCENT CHARLES · 2020 to 2021
$1.7M
Scaling Out and Scaling Up the Systems Analysis and Improvement Approach to Optimize the Hypertension Diagnosis andCare Cascade for HIV-infected Individuals (SCALE SAIA HTN)UG3HL156390 · NHLBI · EDUARDO MONDLANE UNIVERSITY · PI MOCUMBI, ANA OLGA · 2020 to 2021
$1.6M
PULESA-UGANDA-Strengthening the Blood Pressure Care and Treatment cascade for Ugandans living with HIV-ImpLEmentation Strategies to SAve livesUG3HL154501 · NHLBI · INFECTIOUS DISEASES RES COLLABORATION · PI LONGENECKER, CHRIS TODD, SEMITALA, FRED C · 2020 to 2021
$1.5M
Integrating Hypertension and Cardiovascular Disease Care into Existing HIV Service Package in Botswana (InterCARE)UG3HL154499 · NHLBI · UNIVERSITY OF BOTSWANA · PI GAOLATHE, TENDANI, MOSEPELE, MOSEPELE · 2020 to 2021
$1.4M
Application of Implementation Science approaches to assess the effectiveness of Task-shifted WHO-PEN to address cardio metabolic complications in people living with HIV in ZambiaUG3HL156389 · NHLBI · CENTRE FOR INFECTIOUS DISEASE RESEARCH · PI HERCE, MICHAEL EMMANUEL, MUTALE, WILBROAD · 2020 to 2021
$1.3M
NHLBI NIH HHS U24 HL154426NHLBI NIH HHS UG3 HL154499NHLBI NIH HHS UG3 HL154501NHLBI NIH HHS UG3 HL156388NHLBI NIH HHS UG3 HL156389NHLBI NIH HHS UG3 HL156390
6 · The paper itself

Abstract

backgroundHistorically, the focus of cost-effectiveness analyses has been on the costs to operate and deliver interventions after their initial design and launch. The costs related to design and implementation of interventions have often been omitted. Ignoring these costs leads to an underestimation of the true price of interventions and biases economic analyses toward favoring new interventions. This is especially true in low- and middle-income countries (LMICs), where implementation may require substantial up-front investment. This scoping review was conducted to explore the topics, depth, and availability of scientific literature on integrating implementation science into economic evaluations of health interventions in LMICs.

methodsWe searched Web of Science and PubMed for papers published between January 1, 2010, and December 31, 2021, that included components of both implementation science and economic evaluation. Studies from LMICs were prioritized for review, but papers from high-income countries were included if their methodology/findings were relevant to LMIC settings.

resultsSix thousand nine hundred eighty-six studies were screened, of which 55 were included in full-text review and 23 selected for inclusion and data extraction. Most papers were theoretical, though some focused on a single disease or disease subset, including: mental health (n = 5), HIV (n = 3), tuberculosis (n = 3), and diabetes (n = 2). Manuscripts included a mix of methodology papers, empirical studies, and other (e.g., narrative) reviews. Authorship of the included literature was skewed toward high-income settings, with 22 of the 23 papers featuring first and senior authors from high-income countries. Of nine empirical studies included, no consistent implementation cost outcomes were measured, and only four could be mapped to an existing costing or implementation framework. There was also substantial heterogeneity across studies in how implementation costs were defined, and the methods used to collect them.

conclusionA sparse but growing literature explores the intersection of implementation science and economic evaluation. Key needs include more research in LMICs, greater consensus on the definition of implementation costs, standardized methods to collect such costs, and identifying outcomes of greatest relevance. Addressing these gaps will result in stronger links between implementation science and economic evaluation and will create more robust and accurate estimates of intervention costs.

trial registrationThe protocol for this manuscript was published on the Open Science Framework. It is available at: https://osf.io/ms5fa/ (DOI: 10.17605/OSF.IO/32EPJ).

Indexed as

Developing CountriesImplementation ScienceCost-Benefit AnalysisDelivery of Health CareHumansPovertyCost-effectivenessEconomic evaluationImplementation outcomesImplementation scienceInfectious diseaseLow- and middle-income countriesScoping review

Identifiers

PMID36384807
PMCPMC9670396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.